Category Archives: People

Thoma Bravo announces Senior Appointments

Thomas Bravo

Gerald “Jerry” Nowak Joins as General Counsel and Chief Administrative Officer

Jennifer James Promoted to Chief Operating Officer

SAN FRANCISCO—Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, today announced appointments within its senior leadership team in operations.

Gerald “Jerry” Nowak joins Thoma Bravo as a Managing Director and General Counsel, Chief Administrative Officer. Previously, Nowak served as a Partner in the Chicago office of Kirkland & Ellis LLP, where he was a leader in the firm’s Private Equity, M&A and Capital Markets practices, working closely with Thoma Bravo for almost 20 years on a variety of transactions and mandates. In this new role, Nowak will lead Thoma Bravo’s Legal & Compliance, IT and other Administrative functions.

Jennifer James will assume an expanded role as Chief Operating Officer, in addition to her role as Managing Director, Head of Investor Relations and Marketing. During her five-year tenure at Thoma Bravo, James has fostered deep relationships with investors on the firm’s behalf and was instrumental in executing the firm’s recent $22.8 billion fundraise. Thoma Bravo’s Investor Relations, Marketing & Communications, Human Resources and other Operational functions will report to James, who will work closely with Nowak to continue building a best-in-class operations team.

“This was a successful year for Thoma Bravo as we closed our biggest fundraise to date and continued to see growth across our portfolio of leading software and technology companies,” said Orlando Bravo, a founder and Managing Partner at Thoma Bravo. “We begin 2021 in a prime position to take advantage of the many opportunities in the market, supported by a phenomenal team which we are excited to continue to grow. Over the years, Jerry has been a tremendous partner to Thoma Bravo, and I am thrilled to welcome him to our team and continue to work together. His appointment, in addition to Jennifer’s expanded role as COO, reflects the deep bench of talent we have developed. I couldn’t be more excited to work with our growing leadership team as we position the firm for the long-term.”

About Thoma Bravo
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. With more than $73 billion in assets under management as of September 30, 2020, Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make accretive acquisitions intended to accelerate revenue and earnings, with the goal of increasing the value of the business. The firm has offices in San Francisco and Chicago. For more information, visit thomabravo.com.

Read the release on the PR Newswire website here.

Categories: People

Harrison Lung Joins Siris as Partner, Portfolio Value Creation

Siris

New York, January 4, 2021 – Siris, a leading private equity firm focused on investing and driving value creation in technology and telecommunications companies, today announced that Harrison Lung has joined the firm as Partner, Portfolio Value Creation. He most recently served as Partner at McKinsey & Company. Mr. Lung will lead Siris’ Operational Excellence group and work alongside Siris’ teams and Executive Partners to deliver on the value creation potential of Siris portfolio companies across the entire deal lifecycle.

 

For the past decade, Mr. Lung has implemented pivotal strategies across McKinsey’s digital technology and technology-media-telecom (TMT) clients, helping drive transformations and efficiency in digital and technology infrastructure, operations and organizational structures and processes. His combination of deep technology experience and history of improving global businesses will help Siris as it seeks to accelerate growth across its portfolio companies, while reducing costs and enhancing operational efficiency and sophistication.

 

Frank Baker, Co-Founder of Siris, said, “We are excited to welcome Harrison to lead our Operational Excellence group and look forward to benefiting from his experience at McKinsey transforming dynamic technology businesses. We are confident in his ability to help design and implement sophisticated, efficient solutions for our portfolio companies.”

 

Mr. Lung said, “I am thrilled to join Siris as the firm continues to drive growth across technology and telecommunications businesses that deliver mission-critical products and services. I look forward to working with my new colleagues in Siris’ Operational Excellence group to optimize the application of best practices across the portfolio.”

 

Prior to joining McKinsey & Company in 2010, Mr. Lung worked in Accenture’s System Integration, Technical Architecture (Mobile Solutions) and New Business groups, where he served as part of the leadership team that built and scaled an internally incubated startup – Accenture Mobility Operated Service – and facilitated transformative growth for Fortune 500 companies in the pharmaceutical, utility, telecom, chemical and energy sectors.

 

Earlier in his career, Mr. Lung served in technology operating roles in the telecom industry in Canada, at Bell Mobility and Sprint Canada, and was part of the leadership team that implemented Wireless Number Portability. Mr. Lung has been a member of Asia Society’s Global Talent and Diversity Council since 2019 and an ambassador at the Cornell Alumni Admissions Ambassador Network (CAAAN) since 2020.

 

Mr. Lung holds a Bachelor of Applied Science in Computer Engineering from the University of Waterloo and an Executive MBA from Cornell University and Queen’s University.

 

About Siris

 

Siris is a leading private equity firm that invests primarily in mature technology and telecommunications companies with mission-critical products and services, facing industry changes or other significant transitions. Siris’ development of proprietary research to identify opportunities and its extensive collaboration with its Executive Partners are integral to its approach. Siris’ Executive Partners are experienced senior operating executives that actively participate in key aspects of the transaction lifecycle to help identify opportunities and drive strategic and operational value. Siris is based in New York and Silicon Valley and has raised nearly $6 billion in cumulative capital commitments. www.siris.com.

 

Media Contacts

 

Dana Gorman or Blair Hennessy
Abernathy MacGregor
1-212-371-5999
dtg@abmac.com / bth@abmac.com

Categories: People

Torqx Capital Partners further strengthens its investment team

Torqx Capital

Torqx Capital Partners (“Torqx”) is happy to announce that as of January 4th, Lorin Roobrouck has joined the Torqx team as Associate.

Prior to joining Torqx, Lorin worked as an Investment Banking Analyst at Goldman Sachs in London, where she was involved in complex transactions in renewable energy, telecom and transportation. Lorin previously gained experience as an intern in private equity at Gimv and in M&A at EY in Brussels. She holds a specialised M.Sc. in Corporate Finance from ESCP Europe and an M.Sc. in Business Engineering (magna cum laude) from KU Leuven.

Harmen Geerts, Managing Partner at Torqx, comments: “We are delighted to welcome Lorin to our team. Besides being an enormous talented person, Lorin brings a fantastic amount of energy and she shares our passion for building better businesses. We are convinced she will be able to significantly contribute to Torqx’ success and are looking forward to be working with her.”

Categories: People

Altas Welcomes Lisa Dymond

Altas Partners

Lisa Dymond
January 4, 2021

Altas Partners is pleased to announce that Lisa Dymond has joined the firm as Head of Talent. In this newly created role, Lisa will lead talent-related matters at Altas and work with our management team partners to drive organizational effectiveness and success at Altas’ portfolio companies.

Lisa joins Altas from the Boston Consulting Group, where she spent 14 years, most recently leading the end-to-end talent strategy and operations for the firm’s Canadian practice. She previously served in a variety of roles at BCG, leading projects across a range of industries, counselling clients globally, and developing thought leadership on issues related to talent and organization. Lisa began her career in public opinion and market research at Pollara Strategic Insights.

Lisa holds a Bachelor of Arts in Political Science from Carleton University (Dean’s List) and a Master of Business Administration from the University of Western Ontario’s Richard Ivey School of Business (Dean’s List, Valedictorian).

About Altas Partners

Founded in 2012, Altas Partners is an investment firm with a long-term orientation focused on acquiring significant interests in high-quality, market-leading businesses in partnership with outstanding management teams. The firm manages approximately US$7 billion on behalf of endowments, foundations, family offices, public pension funds, and other institutional investors. The firm’s past and present portfolio companies include Unified Women’s Healthcare, DuBois Chemicals, University of St. Augustine for Health Sciences, Tecta America, Hub International, PADI, Medforth Global Healthcare Education, Capital Vision Services (MyEyeDr.), and NSC Minerals. For more information, please visit www.altas.com.

Categories: People

KKR Announces New Managing Directors

KKR

Press Release

<< Back to Press Releases
Download PDF  

KKR Announces New Managing Directors

December 3, 2020

NEW YORK–(BUSINESS WIRE)– KKR today announced a newly promoted group of 26 Managing Directors, effective January 1, 2021.

“We are proud to recognize these senior leaders at KKR for their many accomplishments leading up to this very special milestone,” said Joe Bae and Scott Nuttall, Co-Presidents and Co-Chief Operating Officers of KKR. “Today and every day, we applaud them for their unwavering commitment to delivering for our clients and our companies, and we look forward to seeing all they will achieve in their new roles.”

The following individuals have been promoted to Managing Director at KKR:

  • Anne Arlinghaus – Capstone, New York
  • Brad Bellomo – Audit, New York
  • Dave Blodgett – Technology, Engineering and Data, New York
  • Paula Campbell Roberts – Global Macro Balance Sheet & Risk, New York
  • Bobby Campbell – Credit & Markets, New York
  • David Cheong – Real Estate, Hong Kong
  • Angelique Faustino – Technology, Engineering and Data, New York
  • Cristina Gonzalez – Infrastructure, London
  • Vikram Govindan – Insurance Strategy & Strategic Finance, London
  • Jake Heller – Next Generation Technology, New York
  • Jill Henn – Human Capital, London
  • Franziska Kayser – Private Equity, London
  • Jae Ko – Client and Partner Group, Hong Kong
  • Sanjay Kothari – Technology, Engineering and Data, New York
  • Nonie Lame – Human Capital, New York
  • William Needham – Credit & Markets, London
  • Gabriele Questa – Capstone, London
  • Daniel Rudin – Real Estate, New York
  • Michael Russell – Credit & Markets, San Francisco
  • Kugan Sathiyanandarajah – Health Care Strategic Growth, London
  • Elizabeth Seeger – Public Policy and Affairs (ESG), Washington DC
  • Vance Serchuk – Public Policy and Affairs (KGI), New York
  • Jigar Shah – Corporate NBFC, Legal & Compliance, Mumbai
  • Stephen Shanley – Next Generation Technology, London
  • Deran Taskiran – Capstone, New York
  • Emil Werr – Technology, Engineering and Data, New York

About KKR

KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, credit and real assets, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKR’s investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

Media:
Cara Major or Miles Radcliffe-Trenner
Phone: 212-750-8300
media@kkr.com

Source: KKR

Categories: People

CVC Credit Partners announces two senior hires as it further deepens its Private Credit team

John Empson is joining as Partner and Co-Head of Private Credit, and Miguel Toney is joining as a Partner in the Private Credit team.

CVC Credit Partners (“CVC Credit”) is pleased to announce that John Empson is joining as Partner and Co-Head of Private Credit, and Miguel Toney is joining as a Partner in the Private Credit team.

John has nearly 40 years of experience and is joining from Blackrock where he was Head of Capital Markets, EMEA. Prior to Blackrock, John was a Partner at KKR where he spent 11 years helping with the strategic build out of KKR’s Credit and Markets platform. John was also a member of the KKR EMEA private equity Investment Committee and the KKR EMEA Portfolio Management Committee.

Miguel is joining from Park Square Capital where he has been a Partner focussed on their European junior capital strategy. Prior to this, he was a Managing Director at MV Credit where he helped build out their European junior capital and senior debt capabilities. Across both roles, he has a combined 16 years of experience in private credit.

Alongside Andrew Davies, Partner and Co-Head of Private Credit, Neale Broadhead, Caroline Benton and Chris Fowler, CVC Credit has established a strong senior team focussed on the private credit opportunity and will continue to selectively grow and strengthen the group.

Ken Young, Managing Partner, CVC said: “I am delighted that John and Miguel are joining CVC Credit. They are both incredibly high quality professionals, with very deep experience and a desire to build a world class private credit platform. We expect very significant growth across CVC Credit over the next three to five years. Strategically, this is a huge area of focus for the CVC Group.”

Andrew Davies, Partner and Co-Head, Private Credit added: “I’m very excited John and Miguel are joining. We are hugely committed to increasing our presence as a provider of private credit financing solutions, as recently demonstrated on Curium where we underwrote €315 million of PIK. With these senior additions working alongside the existing team, we are incredibly well positioned to grow this platform.”

Established in 2005, CVC Credit Partners is the dedicated credit arm of CVC with $27 billion of assets under management as at 30 September 2020. The business invests in companies across the sub-investment grade corporate credit markets in Europe and North America, with a strong focus on downside protection through active risk management. It provides investors with a broad range of opportunities to meet their investment criteria through dedicated vehicles and investment solutions for both performing and non-performing credit assets. These investment vehicles benefit from the broad experience of the local investment teams, as well as the unique access to the accumulated knowledge within the broader CVC platform.

Categories: People

Silversmith Capital Partners Expands Advisory Board with Addition of Mike Volpe as New Senior Advisor

Silversmith Capital Partners, a growth equity firm focused on supporting the best entrepreneurs in technology and healthcare, today announced that Mike Volpe, CEO of Lola.com, has joined the firm as a Senior Advisor. With an extensive background leading marketing at high-growth technology companies, Mike will provide strategic value-add to the Silversmith portfolio as they accelerate their growth as well as support due diligence on new investments.

“We have a long-shared history with Mike that goes back decades as a friend, fellow board member and co-investor,” said Jim Quagliaroli, Managing Partner of Silversmith. “Mike was the first person we asked to join the board at Validity at the time of our investment in 2018, and since that time he has joined us as a co-investor in other founder-led companies we have backed, including Appfire. We are excited to now have him join us as a Senior Advisor.  His background will be a significant asset to the Silversmith portfolio as they develop and implement impactful go-to-market strategies.”

Mike is a highly regarded executive with over 20 years of marketing leadership experience in the technology sector. He is active in the Boston SaaS and startup communities as a member of the board of directors of Validity (a Silversmith portfolio company) and Privy, and as an angel investor in more than 30 startups. Mike has served as a strategic individual investor in multiple investments across Silversmith’s first, second, and third funds.

Mike is currently the CEO at Lola.com, a corporate travel SaaS platform that helps companies stop wasting time and start saving money on their business travel programs. Previously he was CMO at Cybereason, a cybersecurity SaaS company, where he helped the company increase its sales pipeline by 650% in a single year and grow revenue by 5x during his tenure. Mike was also part of the founding team at HubSpot, where he spent eight years growing the company from five people to over 1,000 employees, $175 million in revenue, and a successful IPO. He holds an MBA from the MIT Sloan School of Management and a BA from Bowdoin College.

About Silversmith Capital Partners

Founded in 2015, Silversmith Capital Partners is a Boston-based growth equity firm with $2.0 billion of capital under management. Silversmith’s mission is to partner with and support the best entrepreneurs in growing, profitable technology and healthcare companies. Representative investments include ActiveCampaign, Appfire, Centauri Health Solutions, DistroKid, Impact, LifeStance Health, MediQuant, Panalgo, Unily, Validity, and Webflow. The partners have over 75 years of collective investing experience and have served on the boards of numerous successful growth companies including ABILITY Network, Archer Technologies, Dealer.com, Liazon, Liberty Dialysis, MedHOK, Net Health, Passport Health, SurveyMonkey, and Wrike. For more information about Silversmith, please visit www.silversmithcapital.com.

For media Inquiries, please contact:

Kate Castle

Chief Marketing Officer

Silversmith Capital Partners

P: 617.670.4345

kate@silversmithcapital.com

Categories: People

Tags:

Natalie Tydeman joins Kinnevik as Senior Investment Director

Kinnevik

Kinnevik AB (publ) (“Kinnevik”) today announced that Natalie Tydeman will join Kinnevik in January 2021 as Senior Investment Director and member of the management team.

Natalie Tydeman has a successful track record in private equity investing with a focus on fast-growing technology companies within entertainment, education, and health/wellness, extensive senior executive experience in tech/media companies and a deep expertise in new business launches and deployment of new technologies. Natalie is also a seasoned board member and current board positions include Stockholm listed Nordic Entertainment Group and Modern Times Group. Natalie holds an MBA from Harvard Business School and a degree from University of Oxford.

Georgi Ganev, CEO of Kinnevik commented: “I am delighted to welcome Natalie to Kinnevik as a Senior Investment Director. With her long experience in tech-focused investing as well as her operational experience in the media sector, Natalie will be a great addition to our investment team where she will primarily focus on growth investments in Europe. Natalie is a value driven leader with a strong focus on building sustainable companies with a positive impact and I look forward to working with her as we continue our pivot into Europe’s leading public growth investor.“

Natalie Tydeman commented: “Kinnevik combines a highly successful mission driven investment strategy with a strong focus on sustainable business building. From my board positions in NENT and MTG I have had the opportunity to get to know the culture and entrepreneurial spirit that permeates the companies in the Kinnevik family, and I am thrilled to be joining the Kinnevik team.”

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Categories: People

N2 Biomedical Appoints Eric Tobin To Chief Executive Officer

BEDFORD, Mass., Dec. 2, 2020 /PRNewswire/ — N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that its Board of Directors has appointed Eric Tobin to President and Chief Executive Officer. With more than 30 years of experience with the company, Mr. Tobin most recently served as the company’s Chief Operating Officer. In addition to his current responsibilities, he will assume the leadership of all commercial aspects of the organization, as well as overseeing the overall implementation of the corporate growth strategy.

Mr. Tobin has served in numerous senior leadership positions at N2 Biomedical and the company’s previous corporate parent over the last three decades. He has served as Vice President and Chief Operating Officer for the company since September 2013. Prior to N2 Biomedical’s formation, Mr. Tobin joined Spire Biomedical in 1989 and served as Vice President and Chief Operating Officer from 2001-2013, where he was responsible for simultaneously managing the operations of Spire’s surface treatment business and dialysis catheter business unit. Mr. Tobin holds B.S. and M.S. degrees in Applied Physics from the University of Massachusetts at Lowell.

“We are very pleased to have Eric assume the role of Chief Executive Officer at N2,” said Trevor Wahlbrink, a Partner at Ampersand Capital Partners and member of the Board of Directors. “His years of direct experience within the organization and broad skill set uniquely position him to effectively lead the company through its next stage of growth. Under Eric’s leadership, we are confident that N2 will continue to further penetrate the medical device surface treatment and coatings industry with its unique technologies.”

Mr. Tobin commented, “I am truly honored that the Board has selected me to assume the CEO position and am excited about the prospects for the company’s future. We have a dedicated and talented staff, a great foundation of core technologies, and a solid customer base. I look forward to working with the Board and Ampersand to continue providing our customers with the high level of service that they’ve come to expect from us while also building upon our numerous strengths as a company and capitalizing on growth opportunities.”

About N2 Biomedical

Established in 2013, N2 provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 is ISO-13485 certified, FDA GMP-compliant, and operates in a 30,000 square foot facility with laboratory, manufacturing, and cleanroom space to service all customer and regulatory requirements. The company leverages its proprietary processes and equipment to provide customized solutions that enhance the characteristics of various materials in critical applications, including lubricity, infection resistance, biocompatibility and tissue integration, and wear and corrosion resistance. Additional information about N2 Biomedical is available at www.N2bio.com. 

About Ampersand Capital Partners

Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. Additional information about Ampersand is available at ampersandcapital.com. 

Categories: People

N2 Biomedical Appoints Eric Tobin To Chief Executive Officer

BEDFORD, Mass., Dec. 2, 2020 /PRNewswire/ — N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, today announced that its Board of Directors has appointed Eric Tobin to President and Chief Executive Officer. With more than 30 years of experience with the company, Mr. Tobin most recently served as the company’s Chief Operating Officer. In addition to his current responsibilities, he will assume the leadership of all commercial aspects of the organization, as well as overseeing the overall implementation of the corporate growth strategy.

Mr. Tobin has served in numerous senior leadership positions at N2 Biomedical and the company’s previous corporate parent over the last three decades. He has served as Vice President and Chief Operating Officer for the company since September 2013. Prior to N2 Biomedical’s formation, Mr. Tobin joined Spire Biomedical in 1989 and served as Vice President and Chief Operating Officer from 2001-2013, where he was responsible for simultaneously managing the operations of Spire’s surface treatment business and dialysis catheter business unit. Mr. Tobin holds B.S. and M.S. degrees in Applied Physics from the University of Massachusetts at Lowell.

“We are very pleased to have Eric assume the role of Chief Executive Officer at N2,” said Trevor Wahlbrink, a Partner at Ampersand Capital Partners and member of the Board of Directors. “His years of direct experience within the organization and broad skill set uniquely position him to effectively lead the company through its next stage of growth. Under Eric’s leadership, we are confident that N2 will continue to further penetrate the medical device surface treatment and coatings industry with its unique technologies.”

Mr. Tobin commented, “I am truly honored that the Board has selected me to assume the CEO position and am excited about the prospects for the company’s future. We have a dedicated and talented staff, a great foundation of core technologies, and a solid customer base. I look forward to working with the Board and Ampersand to continue providing our customers with the high level of service that they’ve come to expect from us while also building upon our numerous strengths as a company and capitalizing on growth opportunities.”

About N2 Biomedical

Established in 2013, N2 provides coating and surface treatment development and application services for implantable and other medical devices utilized in orthopedic, cardiovascular, and other healthcare end-markets. N2 is ISO-13485 certified, FDA GMP-compliant, and operates in a 30,000 square foot facility with laboratory, manufacturing, and cleanroom space to service all customer and regulatory requirements. The company leverages its proprietary processes and equipment to provide customized solutions that enhance the characteristics of various materials in critical applications, including lubricity, infection resistance, biocompatibility and tissue integration, and wear and corrosion resistance. Additional information about N2 Biomedical is available at www.N2bio.com.

About Ampersand Capital Partners

Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors. Additional information about Ampersand is available at ampersandcapital.com.

Categories: People